You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Mismatch allogeneic cell mediated immunotherapy

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Viral Infections After HSCT Trial in Washington (VSTs)

Active, not recruiting
  • Viral Infections After HSCT
  • VSTs
  • Washington, District of Columbia
    Childrens National Medical Center
Aug 30, 2022

GATA2, Immunodeficiency, MDS Trial run by the National Cancer Institute (NCI) (procedure, drug, biological)

Recruiting
  • GATA2
  • +2 more
  • Allogeneic HSCT
  • +8 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 18, 2022

Head and Neck Squamous-cell Carcinoma

Not yet recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • +2 more
    • (no location specified)
    Nov 5, 2023

    Small Cell Lung Cancer Recurrent Trial in Goyang-si (Atezolizumab)

    Recruiting
    • Small Cell Lung Cancer Recurrent
    • Goyang-si, Gyeonggi-do, Korea, Republic of
      National Cancer Center
    Apr 4, 2022

    Transplantation, Hematopoietic Stem Cell Trial in Lyon (Biological samples (blood and oral fluid))

    Not yet recruiting
    • Transplantation, Hematopoietic Stem Cell
    • Biological samples (blood and oral fluid)
    • Lyon, France
      Hôpital de la Croix Rousse - service des maladies infectieuses e
    Jul 7, 2023

    Advanced Colorectal Carcinoma, Advanced Lung Non-Small Cell Carcinoma, Lung Non-Small Cell Carcinoma Trial in Houston

    Active, not recruiting
    • Advanced Colorectal Carcinoma
    • +24 more
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 20, 2022

    Combined Statin and PD-1/PD-L1 Inhibitors in Treating Non-small

    Recruiting
    • Lung Cancer
    • Yiwu, Zhejiang, China
      The Fourth Affiliated Hospital of Zhejiang University
    Dec 16, 2022

    Metastatic Colorectal Cancer Trial in Bronx, Houston (AlloStim)

    Recruiting
    • Metastatic Colorectal Cancer
    • AlloStim
    • Florham Park, New Jersey
    • +1 more
    Aug 30, 2022

    Acute Myeloid Leukemia in Remission Trial in Worldwide (DCP-001)

    Active, not recruiting
    • Acute Myeloid Leukemia in Remission
    • DCP-001
    • Helsinki, Finland
    • +9 more
    Oct 7, 2022

    Recurrent Endometrial Cancer, Solid Tumors Trial in Pittsburgh (pembrolizumab, Sitravatinib)

    Recruiting
    • Recurrent Endometrial Cancer
    • Solid Tumors
    • Pittsburgh, Pennsylvania
      UPMC Hillman Cancer Center
    Sep 12, 2022

    Clinical Stage I Gastric Cancer AJCC v8, Clinical Stage II Gastric Cancer AJCC v8, Clinical Stage II Gastroesophageal Junction

    Not yet recruiting
    • Clinical Stage I Gastric Cancer AJCC v8
    • +9 more
    • Atezolizumab
    • +12 more
    • (no location specified)
    Apr 26, 2023

    MDS, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Ann Arbor (Pembrolizumab)

    Terminated
    • Myelodysplastic Syndromes
    • +2 more
    • Ann Arbor, Michigan
      University of Michigan Cancer Center
    Nov 1, 2022

    Advanced Hepatocellular Carcinoma Trial in Guangzhou (Bifidobacterium Bifidum Oral Product)

    Recruiting
    • Advanced Hepatocellular Carcinoma
    • Bifidobacterium Bifidum Oral Product
    • Guangzhou, Guangdong, China
      The Third Affiliated Hospital of Sun Yat-Sen University
    Nov 16, 2022

    Acute Myeloid Leukemia, Acute Lymphoid Leukemia, MDS Trial in Leiden (MDG1021 dose 1, MDG1021 dose 2, MDG1021 dose 3)

    Withdrawn
    • Acute Myeloid Leukemia
    • +7 more
    • MDG1021 dose 1
    • +3 more
    • Leiden, Zuid Holland, Netherlands
      Leiden University Medical Centre
    Sep 30, 2021

    Advanced Liver Cancers Trial (DC-CIK)

    Not yet recruiting
    • Advanced Liver Cancers
    • DC-CIK
    • (no location specified)
    Nov 11, 2022

    Non Hodgkin's Lymphoma Trial in Beijing (TRAC and Power3 Genes Knock-out Allogeneic CD19-targeting CAR-T cell (ATHENA CAR-T),

    Not yet recruiting
    • Non Hodgkin's Lymphoma
    • TRAC and Power3 Genes Knock-out Allogeneic CD19-targeting CAR-T cell (ATHENA CAR-T)
    • +2 more
    • Beijing, China
    • +2 more
    Aug 23, 2023

    Metastatic Renal Cell Carcinoma, Metastatic Clear-cell Renal Cancer, Recurrent Renal Cell Carcinoma Trial in Iowa City,

    Completed
    • Metastatic Renal Cell Carcinoma
    • +4 more
    • HyperAcute®-Renal (HAR) Immunotherapy
    • Iowa City, Iowa
    • +2 more
    Apr 4, 2022

    Malignant Sarcoma Trial in Madrid (Natural Killer (NK) cells (a new immunotherapy))

    Recruiting
    • Malignant Sarcoma
    • Natural Killer (NK) cells (a new immunotherapy)
    • Madrid, Spain
      Hospital Universitario La Paz
    Jul 19, 2023

    Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage II HPV-Mediated (p16-Positive)

    Recruiting
    • Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
    • +10 more
    • Intensity-Modulated Radiation Therapy
    • +4 more
    • Houston, Texas
      M D Anderson Cancer Center
    Nov 8, 2022

    Refractory Metastatic Colorectal Cancer, pMMR, MSS Trial in United States (RP2, RP3, atezolizumab)

    Not yet recruiting
    • Refractory Metastatic Colorectal Cancer
    • +2 more
    • RP2
    • +3 more
    • Los Angeles, California
    • +5 more
    Feb 24, 2023

    Lymphoid Leukemia, Acute, Myeloid Malignancy, Plasma Cell Tumor Trial in Miami (T-cell Receptor a/ß Depleted Donor Lymphocyte

    Recruiting
    • Lymphoid Leukemia, Acute
    • +2 more
    • T-cell Receptor α/β Depleted Donor Lymphocyte Infusions
    • Miami, Florida
      Miami Cancer Institute at Baptist Health, Inc
    May 24, 2022

    Metastatic Nonsmall Cell Lung Cancer, Non Small Cell Lung Cancer Trial in Philadelphia (Stereotactic Body Radiotherapy)

    Active, not recruiting
    • Metastatic Nonsmall Cell Lung Cancer
    • Non Small Cell Lung Cancer
    • Stereotactic Body Radiotherapy
    • Philadelphia, Pennsylvania
      Philadelphia CyberKnife
    Mar 15, 2022

    Renal Cell Carcinoma Trial in Switzerland (nivolumab, ipilimumab)

    Active, not recruiting
    • Renal Cell Carcinoma
    • Aarau, Switzerland
    • +13 more
    Oct 17, 2022

    Lymphoproliferative Disorders, Autoimmune Lymphoproliferative, Primary T-cell Immunodeficiency Disorders Trial in Bethesda,

    Recruiting
    • Lymphoproliferative Disorders
    • +4 more
    • Immunosuppression Only Conditioning
    • +3 more
    • Bethesda, Maryland
    • +1 more
    Jan 25, 2023

    Bronchiolitis Obliterans Syndrome, Bronchiolitis Obliterans, Lung Diseases Trial in Boston (Belumosudil, Fluticasone,

    Not yet recruiting
    • Bronchiolitis Obliterans Syndrome
    • +3 more
    • Boston, Massachusetts
    • +3 more
    Jun 27, 2023